DxVx plans to make a license-in agreement of OVM-200
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
Subscribe To Our Newsletter & Stay Updated